En Es
Categories

Industry News

Researchers Develop AI Algorithm to Predict Immunotherapy Response

By Medimaging International staff writers
12 Sep 2018

Image: Researchers have designed an AI algorithm that uses CT scan images to process medical images and extract biological and clinical information (Photo courtesy of iStock).A team of French researchers have designed an algorithm and developed it to analyze Computed Tomography (CT) scan images, establishing for the first time that artificial intelligence (AI) can process medical images to extract biological and clinical information. The researchers have created a so-called radiomic signature, which defines the level of lymphocyte infiltration of a tumor and provides a predictive score for the efficacy of immunotherapy in the patient.

In the near future, this could make it possible for physicians to use imaging to identify biological phenomena in a tumor located anywhere in the body without performing a biopsy.

Currently, there are no markers, which can accurately identify patients who will respond to anti-PD-1/PD-L1 immunotherapy in a situation where only 15 to 30% of patients do respond to such treatment. The more immunologically richer the tumor environment (presence of lymphocytes), the higher is the chances of immunotherapy being effective. Hence, the researchers tried to characterize this environment using imaging and correlate this with the patients’ clinical response. In their study, the radiomic signature was captured, developed and validated genomically, histologically and clinically in 500 patients with solid tumors (all sites) from four independent cohorts.

The researchers first used a machine learning-based approach to teach the algorithm how to use relevant information extracted from CT scans of patients participating in an earlier study, which also held tumor genome data. Thus, based solely on images, the algorithm learned to predict what the genome might have revealed about the tumor immune infiltrate, in particular with respect to the presence of cytotoxic T-lymphocytes (CD8) in the tumor, thus establishing a radiomic signature.

The researchers tested and validated this signature in other cohorts, including that of TCGA (The Cancer Genome Atlas), thus demonstrating that imaging could predict a biological phenomenon, providing an estimation of the degree of immune infiltration of a tumor. Further, in order to test the signature’s applicability in a real situation and correlate it to the efficacy of immunotherapy, it was evaluated using CT scans performed before the start of treatment in patients participating in five phase I trials of anti-PD-1/PD-L1 immunotherapy. The researchers found that the patients in whom immunotherapy was effective at three and six months had higher radiomic scores as did those with better overall survival.

In their next clinical study, the researchers will assess the signature both retrospectively and prospectively, using a larger number of patients and stratifying them based on cancer type in order to refine the signature. They will also use more sophisticated automatic learning and AI algorithms to predict patient response to immunotherapy, while integrating data from imaging, molecular biology and tissue analysis. The researchers aim to identify those patients who are most likely to respond to treatment, thereby improving the efficacy/cost ratio of treatment.



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

24 Sep 2018
Chinese AI System Designed to Predict Diabetes Years in Advance
4 Paradigm, a technology company, is working with Ruijin Hospital to develop a new artificial intelligence (AI) system that will help them to identify patients at risk of developing diabetes up to 15 years in advance. The model named Ruining Knows Sugar, or Ruining Zhitang in Chinese, has achieved an accuracy rate of 88% in tests.
Read More
24 Sep 2018
AI Applied to Micro-Ultrasound Could Speed Cancer Detection
Cambridge Consultants and Exact Imaging are working together to improve the way prostate cancer is visualized and detected by applying deep learning to high-resolution micro-ultrasound imaging. This can help identify potential suspicious regions of tissue and inform urologists who may want to consider this additional data in their biopsy protocol. The early results of their work have been promising.
Read More
24 Sep 2018
AI Program Could Aid Decision-Making in Medical Imaging
Researchers are developing a first of its kind neural network that explains itself and could help with decision-making in the medical field, among others. Raytheon BBN Technologies is developing the neural network under the Defense Research Project Agency's (DARPA) Explainable Artificial Intelligence program (XAI). The aim of the XAI program is to create a suite of machine learning techniques, which produce more explainable models while maintaining a high level of performance. It also aims to help human users understand, appropriately trust and effectively manage the emerging generation of artificially intelligent partners.
Read More
24 Sep 2018
Tetris-Like Program Could Speed Up Breast Cancer Detection
A fully automated medical image analysis program to detect breast tumors that uses a unique style to focus on the affected area is being developed by researchers from the University of Adelaide’s Australian Institute for Machine Learning. Using artificial intelligence (AI), the autonomous program in conjunction with an MRI scan employs the traversal movement and style of a retro video game to examine the breast area.
Read More
20 Sep 2018
Increasing Conditions and Diseases Drive Global POC Hematology Diagnostics Market
The global Point of Care (POC) hematology diagnostics market is expected to grow at a CAGR of close to 9% over the forecast period 2018-2022 to reach a value of USD 2.7 billion by 2022, driven mainly by the rising prevalence of hematology conditions and infectious diseases such as sickle cell disease, thalassemia, and polycythemia. Additionally, the increased adoption of next-generation hematology diagnostic products such as handheld hematology devices and non-invasive hematology testing will further contribute to the growth of the global POC hematology diagnostics market.
Read More
20 Sep 2018
Western Blotting Processors Market to Reach USD 329 Million by 2028
The western blotting processors market is projected to grow at a CAGR of 5.1% from an estimated USD 200 million in 2018 to just under USD 329 million towards the end of 2028, driven partly by the increasing cases of HIV globally as western blot is a confirmed test that can detect anti-HIV antibodies in blood serum samples.
Read More
18 Sep 2018
Digital X-ray Market to Reach USD 13 Billion by 2023
The digital X-ray market is expected to grow at a CAGR of 8.5% from USD 8.68 billion in 2018 to USD 13.04 billion by 2023, driven by a growing geriatric population and resultant increase in the incidence of global diseases, favorable regulations and government initiatives & investments, increased advantages of digital X-ray systems, and technological advancements and product development.
Read More
18 Sep 2018
Study Examines How Medical Device Industry Can Increase Success
An aging global population, growing health awareness, and rising income levels in most emerging markets are driving the need and opportunity for high-quality medical device solutions in these regions. However, in order to capture market share in growth regions such as Asia-Pacific (APAC) and Latin America (LATAM), medical device organizations need to align their emerging-market strategies and business models in line with the regulatory and business landscapes prevailing in the target countries and markets.
Read More
12 Sep 2018
Fujifilm and IU School of Medicine to Study AI in Diagnostic Imaging
Fujifilm Corporation has entered into a joint research agreement with Indiana University School of Medicine to develop the application of artificial intelligence (AI) in medical imaging diagnostic support systems.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions